VVOS - Vivos Therapeutics, Inc. -  [ ]

Ticker Details
Vivos Therapeutics, Inc.
IPO Date: July 7, 2020
Sector: Healthcare
Industry: Medical Devices
Market Cap: $6.47M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.20 | 6.02%
Avg Daily Range (30 D): $0.04 | 7.11%
Avg Daily Range (90 D): $0.06 | 6.02%
Institutional Daily Volume
Avg Daily Volume: .28M
Avg Daily Volume (30 D): 3.11M
Avg Daily Volume (90 D): 1.2M
Trade Size
Avg Trade Size (Sh.): 87
Avg Trade Size (Sh.) (30 D): 408
Avg Trade Size (Sh.) (90 D): 361
Institutional Trades
Total Institutional Trades: 25
Avg Institutional Trade: $.96M
Avg Institutional Trade (30 D): $.65M
Avg Institutional Trade (90 D): $.65M
Avg Institutional Trade Volume: .03M
Avg Institutional Trades (Per Day): 3
Market Closing Trades
Avg Closing Trade: $1.05M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $.84M
Avg Closing Volume: 12.46K
 
News
Jun 8, 2026 @ 5:39 PM
Vivos Therapeutics To Participate in the Small Cap...
Source: Na
Jan 21, 2026 @ 6:00 PM
Global Sleep Apnea Devices Market is Expected to C...
Source: Delveinsight
Jan 20, 2026 @ 10:31 PM
Vivos Therapeutics Announces Closing of Exercise o...
Source: Na
Dec 15, 2025 @ 10:30 PM
Vivos Therapeutics to Participate in Online Firesi...
Source: Vivos Therapeutics, Inc.
Aug 20, 2025 @ 8:24 PM
Vivos Reports 7% Sales Drop
Source: Jesterai
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $-2.14 $-.52 $-.58
Diluted EPS $-2.14 $-.52 $-.58
Revenue $19.57M $5.14M $3.82M
Gross Profit $12.09M $3.06M $2.99M
Net Income / Loss $-25.12M $-7.75M $-6.95M
Operating Income / Loss $-22.6M $-6.62M $-6.38M
Cost of Revenue $7.47M $2.08M $.84M
Net Cash Flow $-4.23M $M $-1.06M
PE Ratio    
Splits
Oct 27, 2023 1:25